Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #155
- Final score
- 63.08
- Years on list
- 5
↗ Climbed 265 since 2021
Compare · Up to four Russell 1000 companies
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
Figure 01 · Side-by-side summary
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 265 since 2021
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 221 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 401 since 2020
Figure 02 · Rank trajectory
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2025
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | VTRS | DHR | MRNA |
|---|---|---|---|
| Climate Change | 69.5 | 70.7 | 77.8 |
| Employee Relations | 62.2 | 74.8 | 47.7 |
| Environment | 69.4 | 54.7 | 50.8 |
| Stakeholders & Society | 67.5 | 65.9 | 83.9 |
| Human Rights | 41.2 | 55.2 | 60.4 |
| Governance | 53.7 | 48.8 | 50.8 |
| Performance Rating | 67.9 | 59.6 | 64.1 |